Mitchell Blutt, MD, leads Consonance Capital in New York as the company’s founder and CEO. A recipient of multiple commendations for his performance and dedication in the healthcare and business sectors, Dr. Mitchell Blutt received recognition in three Marquis Who’s Who listings. Marquis Who’s Who represents the standard for comprehensive biographical data and honors the contributions of leaders. Recipients include prominent national and international players from a broad array of industries and fields.
Originally established in 1899, Marquis Who’s Who continues to evolve as it adapts to the needs of its patrons. It also focuses on the development of new and convenient methods of relaying biographical data while maintaining its emphasis on quality. As a means of keeping up with society’s reliance on technology, Marquis publishes both traditional print editions and the newly released digital edition, Marquis Biographies Online.
Marquis Biographies Online is a powerful web tool that allows real-time access to the Marquis database and the capacity for targeted searches. Searches can be conducted using a variety of parameters, such as name, occupation, education, and geographic location.
Mitchell Blutt is a New York City-based physician and investment professional. In 2005, following almost two decades of experience as an executive partner for JP Morgan Partners, he founded Consonance Capital, a groundbreaking healthcare investment firm based in New York City. Even with his busy schedule, Mitchell Blutt remains actively involved in the boards of companies and organizations, such as the National Venture Capital Association (NVCA).
The NVCA considers itself to be the premier organization representing the country’s venture capital community. The organization empowers its members to fund today's most innovative entrepreneurs by advocating for policies that not only fortify innovation, but also rewards long-term investments.
As an active advocate for its target community, NVCA was recently involved in reviewing an important foreign investment bill. The Foreign Investment Risk Review Modernization Act (FIRRMA) of 2017, was meant to expand the mandate of the Committee on Foreign Investment in the United States (CFIUS), enabling it to review minority investments in critical domestic technology companies.
On behalf of the U.S. entrepreneurial ecosystem, the NVCA suggested several changes, including amending the passive investment exemption in the resolution, expanding exempted countries, and removing any stifling factors affecting foreign strategic investors. These proposed changes are meant to mitigate potential harm to U.S. startups, which rely on external funding to hit the ground running.
An investment professional who also stands out as a physician and medical professor, Dr. Mitchell Blutt currently serves as the CEO of Consonance Capital, a New York City-based investment firm. One of the first to specialize in health care-related investments, Dr. Mitchell Blutt has served on the boards for numerous organizations, including the board of trustees of the Perelman School of Medicine at the University of Pennsylvania.
Recently, the Perelman School of Medicine announced that two members of its faculty won highly competitive Sloan Research Fellowships, which includes $65,000 in research funding. Since 1955, the fellowship has been awarded to young scholars who demonstrate they are among the most promising scientific researchers in their field. Fellowships are given in the areas of economics, chemistry, molecular biology, mathematics, neuroscience, and other fields.
An assistant professor of neuroscience, Shinjae Chung, Ph.D., and an assistant professor of genetics, Iain Mathieson, Ph.D., received the Sloan award in 2018. Dr. Chung will use her fellowship to study the mechanisms that control sleep and their relationship to the circuits that regulate emotional states. Dr. Mathieson plans to use his fellowship to study human genetic structure and how it has impacted human evolution and disease throughout history.
Consonance Capital founder and CEO Mitchell Blutt possesses more than three decades of combined experience in the financial and healthcare sectors. A clinical assistant professor of medicine for Cornell University Weil Cornell Medicine, Mitchell Blutt also belongs to the New York Academy of Medicine. Among the academy’s upcoming events is the Urban Health Informatics Innovation Conference & Exhibit.
The Urban Health Informatics Innovation Conference & Exhibit will showcase innovations and prototypes that contribute to urban healthcare improvements through the use of health informatics. Information at this evening event will be delivered through an assortment of presentation stations that address numerous health care applications and uses. Stations feature innovative informatics solutions and allow participants to expand their understanding by connecting with presenting developers, health care professionals, and logistics professionals.
Participants may enjoy light refreshments while exploring presentation stations and networking with colleagues. Group presentation spokespersons will also summarize their innovations in 10-minute presentations toward the end of the event, and there will be a keynote address in advance of a final Q&A session.
Co-sponsored by Academy Health Informatics Workgroup and the Nursing Section, the event will take place on April 30, 2018, at the New York Academy of Medicine.
Mitchell Blutt, MD, is the founder and CEO of Consonance Capital, an investment firm in New York that invests in numerous opportunities across the field of health care. In addition to his work with the firm, Dr. Mitchell Blutt maintains a membership with the New York Academy of Medicine (NYAM), which is preparing for its 2016 Annual Gala at New York City’s five-star Mandarin Oriental, New York Hotel.
NYAM’s Annual Gala features a black-tie or national dress event that brings members together to celebrate accomplishments and highlight commitments to the organization’s objectives. Galas provide recognition to companies, organizations, and professionals that use technology to improve health-care opportunities. Additionally, the gala will announce award recipients for the eCaring with the Corporate Leadership Award and the Health Information Tool for Empowerment and Older Adults Technology Services.
The 2016 Annual Gala will take place on the evening of June 14 with the theme of Healthy Cities. Better Lives. Ticket prices vary according to NYAM membership and seating selection. Attending organizations and company representatives may also purchase advertising space in the gala program booklet.
Establishing Consonance Capital a decade ago, Mitchell Blutt pioneered the practice of health-care investment. Concurrently, Mitchell Blutt serves as a professor at Weill Cornell Medical College, where he also sits on the Dean’s Council.
An advocate of Weill Cornell Medical College’s academic, research, and patient care initiatives, the Dean’s Council serves as a voice for the institution. Council members promote the medical college’s research within the community to raise philanthropic funds supporting the school’s programs.
Individuals seeking to support Weill Cornell Medical College have several options for making a contribution.
1. Monetary donations paid with a credit card can be made online at www.give.weill.cornell.edu. One-time gifts can also be made by calling (866) 329-8915 or mailing the gift to the Office of External Affairs at 1300 York Avenue, Box 314, New York, New York, 10065. Individuals interested in making a donation in the form of cash or stock transfers should contact the school for instructions.
2. To contribute recurring gifts, ongoing contributions can be made through Partners in Medicine or the Stimson Society. Additionally, name giving and endowment opportunities are available for donors interested in making long-term contributions.
3. Whether a will, life insurance policy or donor-advised fund, a supporter of the school may name the institution as a beneficiary of their estate. For more details, donors should contact the planned giving officer at (646) 317-7400.